WV NORML & Cannabis Advocacy — Johnson, Williams, Dawson, Yeager

Last verified: May 2026

West Virginia NORML

West Virginia NORML is the Mountain State chapter of the National Organization for the Reform of Marijuana Laws — the principal patient-rights, civil-liberties, and decriminalization advocacy organization in WV. Per published organizational identification:

• Jesse Johnson — Executive Director. The most consistent public-facing WV NORML voice in legislative testimony, media commentary, and patient-coalition organizing
• Rusty Williams — Board Member. Long-tenured WV NORML voice on patient rights and decriminalization
• David Dawson — Legal Counsel. The organization’s primary legal voice on SB 386 implementation, conditional discharge, and decriminalization advocacy

WV NORML’s SB 386 campaign work in 2014–2017 was a key element of the political coalition that delivered the Medical Cannabis Act. The organization’s post-enactment work has focused on:

• Decriminalization of small-amount possession (Sen. Woelfel SB 219 model, 15 g threshold)
• Patient workplace protections
• Edibles authorization (HB 5260 / SB 892)
• Patient home cultivation (HB 5259)
• Critique of the 3 ng/mL per se DUI rule for registered patients (the "patient trap")
• Racial-disparity remediation (per ACLU analysis: Black West Virginians arrested at 7.3 times the rate of white West Virginians)

West Virginia Compassion Coalition

The West Virginia Compassion Coalition is a patient-centered advocacy organization organized around the qualifying-condition population — particularly chronic-pain, PTSD, cancer, MS, Parkinson’s, and pediatric epilepsy patient families. The coalition has been a key voice in OMC Medical Cannabis Advisory Board (MCAB) proceedings, in patient-testimony hearings on HB 5260 (edibles), and in the long-running campaign to add OUD (opioid use disorder) as a qualifying condition under W. Va. Code § 16A-2-1. The OUD qualifying-condition petition has been pending across multiple MCAB review cycles; despite West Virginia’s acute opioid context, OUD is not currently on the qualifying-conditions list. See qualifying conditions page.

Marijuana Policy Project (MPP) — Matt Simon

The Marijuana Policy Project, the Washington-D.C.-based national reform organization, was a central operational partner in the SB 386 (2017) campaign. MPP’s principal West Virginia voice is Matt Simon, a WVU graduate and West Virginia native who served as MPP’s lead political director on the WV campaign and remains the organization’s WV media voice. Simon’s post-SB-386 statement captured the framing that carried passage: "Medical marijuana can be effective in treating a variety of debilitating conditions and symptoms, and for many patients, medical marijuana is a far safer alternative to opioids and other prescription drugs."

MPP’s post-2017 West Virginia work has focused on incremental medical-program expansion (edibles, OUD qualifying condition) and patient-protection issues, in coordination with WV NORML and the Compassion Coalition. MPP also tracks West Virginia in its national reform-bill scorecard. See SB 386 page.

Appalachian Cannabis Company — Chris Yeager

Chris Yeager, founder and CEO of Appalachian Cannabis Company, is one of the most visible industry voices in West Virginia cannabis policy. The company is involved in cultivation, processing, and retail, and Yeager has been a consistent media voice on the cross-border-flow problem (Maryland, Ohio adult-use legalization hollowing out West Virginia program revenue), the no-edibles restriction’s commercial impact, and the industry case for HB 5260. Yeager’s framing differs from WV NORML’s patient-rights frame in that it emphasizes commercial-program viability — but the policy asks (edibles, expanded product forms, retention of WV-program patient base) align. See WV dispensary overview.

The Joint Legislative Strategy

Across WV NORML, the Compassion Coalition, MPP, and the operator coalition (which includes the major MSOs — Trulieve, Verano, Holistic, Curaleaf, Cannabist — plus WV-based operators like Harvest Care, Mountaineer Holding, and Appalachian Cannabis), the 2025–2026 reform-cycle priorities have converged:

• Edibles authorization (HB 5260 / SB 892) — the single most achievable expansion
• OUD as qualifying condition — an MCAB petition path that does not require legislation
• Patient workplace protections — non-discrimination for registered patients in non-safety-sensitive roles
• Decriminalization at 15 g threshold (SB 219 model) — addresses the racial-disparity arrest problem
• Patient home cultivation (HB 5259) — rural-access and chronic-cost relief

None of these advanced in 2026. The coalition’s 2027 strategy focuses on Senate Health Committee engagement, where the bills die. See HB 5260 page.

The No-Citizen-Initiative Constraint

WV NORML, the Compassion Coalition, and MPP all operate under the central structural constraint of West Virginia cannabis politics: there is no citizen-initiative ballot path. Maryland’s Question 4, Ohio’s Issue 2, Missouri’s Amendment 3, Michigan’s Proposal 1 — the consumer-led ballot mechanisms that produced legalization in those states are unavailable in West Virginia. The Mountain State is one of exactly 24 U.S. states with no statutory or constitutional initiative process. WV NORML’s work is accordingly entirely legislative-lobbying-shaped — meeting with members, drafting bill language, mobilizing patient testimony, and working the Senate Health and Judiciary committees. See no-citizen-initiative page.

The Patient-Voice Imperative

The 2026 House floor passage of HB 5260 was driven in substantial part by patient testimony — respiratory-condition patients explaining why oral dosing matters when vaporization is contraindicated; cancer-survivor patients explaining the 30-day-supply hardship; chronic-pain patients explaining the cost of registration plus dispensary retail. WV NORML, the Compassion Coalition, and Appalachian Cannabis have consistently prioritized this patient-voice approach in committee hearings. The Senate-Committee-side patient testimony in 2027 will be the binding test of whether HB 5260 (or its successor) clears the firewall.

The Mountain State’s Modest Reform Infrastructure

West Virginia’s cannabis-advocacy infrastructure is small. WV NORML, the Compassion Coalition, MPP, and the industry voices listed above do not match the staffing, funding, or political muscle of cannabis advocacy in California, Colorado, or New York. The Mountain State’s small population (~1.78 million per Census Bureau May 2026 estimates) and limited cannabis-industry employment (~2,000 direct + indirect jobs per OMC March 2026) shape the funding base. Within those constraints, the WV NORML / Compassion Coalition / MPP / industry coalition has produced the principal legislative records of the post-SB-386 decade. The work continues. See WV legislative reform coalition.